Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license

Sensitive

Endometrial cancer

near PVT1 · rs10505508

Strength of the evidence

1 / 4

Its strongest genetic-study result is p = 10−8, with 1 associations in the GWAS Catalog.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied 1,200 East Asian ancestry female cases, 60,614 East Asian ancestry female controls, 16,078 European ancestry female cases, 228,566 European ancestry female controls; replicated in 718 European ancestry female cases, 1,206 European ancestry female controls, 100 Central Asian ancestry female cases, 489 Central Asian ancestry female controls, 22 Asian ancestry female cases, 9 Asian ancestry female controls.

The effect Each copy of the T allele carried 0.92 times the odds of Endometrial cancer (95% confidence interval 0.89-0.94); p = 5 × 10−9.

How common The T allele had a frequency of about 32% in the people studied.

Where it sits Chromosome 8, band 8q24.21 — between genes, 15.5 kb from PVT1.

How common each version is

CT
Japanese ToMMo
C 100.0%
Vietnamese
C 99.5% · T 0.5%
World gnomAD
C 79.7% · T 20.3%
World 1000 Genomes
C 89.8% · T 10.2%
World TOPMed
C 81.7% · T 18.4%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study. No Korean figure for this position yet.

What each result means

C/C No copy of the version the research linked to Endometrial cancer. This is the starting point the study compared everyone against.
C/T One copy of the version the research linked to Endometrial cancer. That is a smaller link than two copies.
T/T Two copies of the version the research linked to Endometrial cancer. That is the strongest link of the three results. A link in a study is not a diagnosis.
Source

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

Endometrial cancer (rs10505508). MyGeneLog™. https://www.mygenelog.com/variants/rs10505508

← See all variants